Insider Trading: Onyx Pharmaceuticals Inc (ONXX.O)

ONXX.O on Nasdaq

95.23USD
24 May 2013
Price Change (% chg)

$-0.97 (-1.01%)
Prev Close
$96.20
Open
$95.66
Day's High
$96.07
Day's Low
$94.00
Volume
464,281
Avg. Vol
1,187,882
52-wk High
$101.57
52-wk Low
$41.26

Search Stocks
SHEMA SUZANNE M Options Exercised: 0
Trade Date: Wednesday, 6 Jun 2012 Price: 32.07
Title: General Counsel Shares Held: 53,639
Type Traded: Direct Net Change in Shares This Filing: 0
» More Insider Trading

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 336
Total Shares Held: 76,413,411
3 Mo. Net Change: 3,427,645
# New Positions: 52
# Closed Positions: 46
# Increased Positions: 174
# Reduced Positions: 145
# Net Buyers: 29

Officers & Directors

Name Age Since Current Position

N. Anthony Coles

 52 2012 Chairman of the Board, President, Chief Executive Officer

Matthew Fust

 48 2009 Chief Financial Officer, Executive Vice President

Suzanne Shema

 55 2012 Executive Vice President, General Counsel, Corporate Secretary

Pablo Cagnoni

 48 2013 Executive Vice President - Global Research & Development and Technical Operations

Juergen Lasowski

 55 2011 Executive Vice President - Corporate Development and Strategy

Helen Torley

 50 2011 Executive Vice President, Chief Commercial Officer

Kaye Foster-Cheek

 53 2010 Senior Vice President - Global Human Resources

Julianna Wood

 57 2011 Vice President - Public Affairs

Paul Goddard

 63 2008 Lead Independent Director

Antonio Grillo-Lopez

 73 2002 Independent Director

Magnus Lundberg

 57 2000 Independent Director

Corinne Nevinny

 53 2005 Independent Director

William Ringo

 67 2011 Independent Director

Wendell Wierenga

 65 1996 Independent Director

Thomas Wiggans

 61 2005 Independent Director

Amy Figueroa

 IR Contact Officer
Search Stocks